Author

Marco Fornili 1

1 University of Pisa, Pisa, Italy

BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY

Lorenzo Bertani, Luca Antonioli, Marco Fornili, Vanessa D'Antongiovanni, Francesca Coppini, Ceccarelli Linda, Laura Benvenuti, Maria Gloria Mumolo, Laura Baglietto, Massimo Bellini, Matteo Fornai, Nicola De Bortoli, Francesco Costa

ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE

Lorenzo Bertani, Claudia D'Alessandro, Marco Fornili, Francesca Coppini, Federico Zanzi, Francesca Geri, Maria Gloria Mumolo, Linda Ceccarelli, Laura Baglietto, Massimo Bellini, Francesco Costa, Nicola De Bortoli

Item 1 - 2 / 2
1